Breaking News

Simtra Biopharma Solutions Announces $250M Sterile Fill/Finish Expansion

New 150,000 sq.-ft. building will house two high-speed automated isolator syringe fill lines and a new high speed isolator vial line.

Author Image

By: Charlie Sternberg

Associate Editor

Simtra BioPharma Solutions, an injectable contract development and manufacturing organization (CDMO), has announced a $250+ million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana. About the Expansion A new 150,000 square foot building will be constructed to house two high-speed automated isolator syringe fill lines and a new high speed isolator vial line equipped with three 30 square meter lyophilizers. Each process suite in the new building will be fitted...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters